Plasticity beyond Cancer Cells and the "Immunosuppressive Switch"

被引:75
|
作者
Granot, Zvi [1 ]
Fridlender, Zvi G. [2 ]
机构
[1] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Sch Med, IL-91010 Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Inst Pulm Med, Jerusalem, Israel
关键词
REGULATORY T-CELLS; TGF-BETA; MACROPHAGE ACTIVATION; ANGIOGENIC SWITCH; TUMOR PROGRESSION; DENDRITIC CELLS; FIBROBLASTS; DIFFERENTIATION; METASTASIS; MICROENVIRONMENT;
D O I
10.1158/0008-5472.CAN-15-1502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor initiation, growth, and metastatic progression are complex processes that, in order to be successful, require extraordinary cellular plasticity. Accordingly, tumor cell plasticity and how it affects disease progression have been studied extensively. However, as our understanding of the tumor microenvironment deepens, we are confronted with the notion that functional plasticity in the context of cancer is not limited to tumor cells alone but is also commonly seen in normal stromal cells of the microenvironment, and specifically in immune cells. Here, we review the functional plasticity these cells exhibit in the context of cancer, highlighting the role of circulating and tumor-associated neutrophils. We further discuss how this plasticity supports or limits tumor progression, inducing an "immunosuppressive switch" to promote further tumor growth and development. (C) 2015 AACR.
引用
收藏
页码:4441 / 4445
页数:5
相关论文
共 50 条
  • [21] Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells
    Kim, So-Jung
    Ha, Ga-Hee
    Kim, Sun-Hee
    Kang, Chi-Dug
    IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (06) : 517 - 534
  • [22] Plasticity of Innate Lymphoid Cells in Cancer
    Heinrich, Bernd
    Korangy, Firouzeh
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy
    Zheng, Xiaobo
    Yu, Chune
    Xu, Mingqing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells
    Alizadeh, Darya
    Larmonier, Nicolas
    CANCER RESEARCH, 2014, 74 (10) : 2663 - 2668
  • [25] Peptide-based targeting of immunosuppressive cells in cancer
    Trac, Noah T.
    Chung, Eun Ji
    BIOACTIVE MATERIALS, 2020, 5 (01) : 92 - 101
  • [26] Regulatory T cell plasticity: beyond the controversies
    Hori, Shohei
    TRENDS IN IMMUNOLOGY, 2011, 32 (07) : 295 - 300
  • [27] Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
    Jie, H-B
    Gildener-Leapman, N.
    Li, J.
    Srivastava, R. M.
    Gibson, S. P.
    Whiteside, T. L.
    Ferris, R. L.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2629 - 2635
  • [28] Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
    Ma, Jie
    Xu, Huaxi
    Wang, Shengjun
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [29] Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer
    Li, Lingfei
    Li, Mingyang
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [30] Breast-cancer stem cells-beyond semantics
    Badve, Sunil
    Nakshatri, Harikrishna
    LANCET ONCOLOGY, 2012, 13 (01) : E43 - E48